Peanut Intake Linked to Lipid Changes and Lower Type 2 Diabetes Risk
A study from the German Institute of Human Nutrition and the University of Barcelona found that eating peanuts changes the body's circulating lipid profile in a pattern linked to lower type 2 diabetes risk. Published in The American Journal of Clinical Nutrition, the work combined intervention and cohort data to show measurable remodeling of blood lipids. Peanuts are rich in very-long-chain saturated fatty acids and monounsaturated fats, which may help explain metabolic effects beyond their calorie content.
The research paired a six-month randomized trial with a large cohort. In ARISTOTLE, 63 healthy adults aged 18–33 received 25 g/day skin-roasted peanuts, 32 g/day peanut butter, or 32 g/day control butter containing peanut oil. EPIC-Potsdam followed over 27,000 people and included 774 new type 2 diabetes cases and 545 cardiovascular cases.
Peanuts, botanically legumes, supply very-long-chain saturated fatty acids—chains longer than 20 carbons—and monounsaturated fats. Investigators linked a distinct peanut-related lipidomic pattern to lower type 2 diabetes risk, suggesting effects beyond calories, though mechanisms remain incompletely understood.
These findings could shape dietary advice for people concerned about type 2 diabetes or cardiovascular risk, and may interest clinicians, nutrition researchers, and food producers. If confirmed, peanut-related lipid changes might offer a practical food-based target alongside overall diet quality. Yet effects may vary by person, and peanuts still contribute calories, so the results should not be read as a universal prescription.